Australian Clinical Labs
ACL.AX
#7129
Rank
โ‚น33.58 B
Marketcap
โ‚น169.15
Share price
2.64%
Change (1 day)
26.76%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2023: โ‚น10.08

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is โ‚น10.08. In 2023 the company made an earnings per share (EPS) of โ‚น10.08 a decrease over its 2022 EPS that were of โ‚น51.85.

EPS history for Australian Clinical Labs from 2021 to 2023

Annual EPS

Year EPS Change
2023โ‚น10.08-80.55%
2022โ‚น51.85104.3%
2021โ‚น25.38